查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1428206

2024 年肿瘤学和免疫学流式细胞技术全球市场报告

Flow Cytometry In Oncology And Immunology Global Market Report 2024
出版日期: 按订单生产 | 出版商: The Business Research Company | 英文 175 Pages | 商品交期: 2-10个工作天内

价格
简介目录

流式细胞技术在肿瘤学和免疫学领域的市场规模预计在未来几年将快速成长。预计到 2028 年将以 10.0% 的复合年增长率 (CAGR) 增长至 30.7 亿美元。预测期内的预期增长可归因于基因组学和蛋白​​质组学的整合、单细胞分析的日益采用、感染疾病应用的扩大、癌症发病率的增加以及照护现场流式细胞技术。预测期内预计出现的显着趋势包括免疫治疗的免疫表型分析、流式细胞技术系统的小型化、多参数分析、向频谱流式细胞技术的过渡以及合作研究倡议。

癌症发生率的预期增加预计将推动流式细胞技术在肿瘤学和免疫学领域的发展。癌症是一组以不受控制的细胞增殖为特征的疾病，是流式细胞技术在癌症和免疫细胞研究中的重要关注领域。例如，麦克米伦癌症支持组织在2022 年10 月报告称，2020 年将有约300 万人受到癌症影响，预计到2025 年将达到350 万人，到2030 年将达到400 万人，预计到2040年这数字将增至530 万人。这是推动流式细胞技术在肿瘤学和免疫学领域发展的关键因素。

爱滋病毒/爱滋病的日益流行预计将有助于肿瘤学和免疫学领域流式细胞技术市场的扩大。爱滋病毒是一种影响免疫系统并造成全球健康问题的病毒。流式细胞技术透过分析细胞，特别是免疫细胞的物理和化学特性，在爱滋病毒/爱滋病研究和临床应用中发挥重要作用。截至 2023 年 7 月，世界卫生组织报告称，到 2022 年，将有约 3,900 万人感染爱滋病毒，估计范围为 3,310 万至 4,570 万人。同一时期，约 63 万人死于爱滋病毒相关原因，信赖区间为 48 万至 88 万。此外，2022年，约有130万人感染爱滋病毒，范围在100万至170万之间。因此，爱滋病毒/爱滋病盛行率的上升是流式细胞技术在肿瘤学和免疫学领域发展的关键驱动力。

目录

第一章执行摘要

第二章 市场特点

第三章 市场趋势与策略

第四章宏观经济情景

  • 高通膨对市场的影响
  • 乌克兰与俄罗斯战争对市场的影响
  • COVID-19 对市场的影响

第五章世界市场规模与成长

  • 全球流式细胞技术在肿瘤学和免疫学市场的驱动因素和阻碍因素
    • 市场驱动力
    • 市场限制
  • 全球流式细胞技术在肿瘤学和免疫学市场规模、表现和成长，2018-2023
  • 全球肿瘤学及免疫学流式细胞技术仪市场规模及成长预测，2023-2028、2033

第六章市场区隔

  • 全球肿瘤学和免疫学中的流式细胞技术，按类型、性能和预测细分，2018-2023、2023-2028、2033
  • 免疫学
  • 肿瘤学
  • 全球肿瘤学和免疫学中的流式细胞技术，按技术、性能和预测细分，2018-2023、2023-2028、2033
  • 基于细胞的
  • 以微珠为基础
  • 流式细胞技术在全球肿瘤学和免疫学的应用、性能和预测细分，2018-2023、2023-2028、2033
  • 转化研究
  • 临床调查
  • 全球肿瘤学和免疫学中的流式细胞技术，最终用户的细分、性能和预测，2018-2023、2023-2028、2033
  • 医院
  • 诊断实验室
  • 参考实验室
  • 製药和生物技术公司
  • 学术研究所
  • 合约研究组织
  • 其他最终用户

第 7 章 区域与国家分析

  • 流式细胞技术在全球肿瘤学和免疫学中的应用，按地区、性能和预测，2018-2023、2023-2028、2033
  • 流式细胞技术在全球肿瘤学和免疫学中的应用，按国家、性能和预测，2018-2023、2023-2028、2033

第八章亚太市场

第九章 中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第14章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章 德国市场

第十八章 法国市场

第十九章 义大利市场

第20章 西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章加拿大市场

第26章 南美洲市场

第27章 巴西市场

第28章 中东市场

第29章 非洲市场

第三十章 竞争形势及公司概况

  • 流式细胞技术在肿瘤学和免疫学领域的竞争形势
  • 肿瘤学和免疫学流式细胞技术公司简介
    • Thermo Fisher Scientific Inc.
    • Danaher Corporation
    • Merck KGaA
    • Becton Dickinson and Company
    • Laboratory Corporation of America Holdings

第31章 其他大型创新公司

  • Agilent Technologies Inc.
  • Sartorius AG
  • Beckman Coulter Inc.
  • Bio-Rad Laboratories Inc.
  • Sysmex Partec GmbH
  • OPKO Health Inc.
  • Miltenyi Biotec
  • NeoGenomics Laboratories Inc.
  • Luminex Corporation
  • Q2 Solutions LLC
  • Enzi Biochem Inc.
  • DiaSorin SpA
  • BioLegend Inc.
  • Cytek Biosciences Inc.
  • Cell Signaling Technology Inc.

第32章竞争基准化分析

第 33 章. 竞争对手仪表板

第三十四章 重大併购

第35章 未来前景与可能性分析

第36章附录

简介目录
Product Code: r14050

Flow cytometry, as applied in oncology and immunology, denotes a technology and methodology utilized to analyze and characterize cells based on their physical and chemical attributes.

The primary categories of flow cytometry in oncology and immunology encompass immunology and oncology. Immunology, a field within biomedical science, explores the immune system and its reactions to foreign substances referred to as antigens. Within the realms of oncology and immunology, flow cytometry involves diverse technologies, including cell-based flow cytometry and bead-based flow cytometry. These technologies find applications in various contexts such as translational research and clinical research. The end users of flow cytometry in this context encompass hospitals, diagnostic laboratories, reference laboratories, pharmaceutical and biotechnology companies, academic research institutes, contract research organizations, among others.

The flow cytometry in oncology and immunology research report is one of a series of new reports from The Business Research Company that provides flow cytometry in oncology and immunology market statistics, including the flow cytometry in oncology and immunology industry's global market size, regional shares, competitors with flow cytometry in oncology and immunology market share, detailed flow cytometry in oncology and immunology market segments, market trends and opportunities, and any further data you may need to thrive in the flow cytometry in oncology and immunology industry. This flow cytometry in oncology and immunology market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The flow cytometry in oncology and immunology market size has grown rapidly in recent years. It will grow from $1.89 billion in 2023 to $2.1 billion in 2024 at a compound annual growth rate (CAGR) of 10.9%. The growth observed in the historical period can be credited to progress in cancer research, expansion in immunology research, diagnostic applications, an increase in autoimmune diseases, and the undertaking of drug development and clinical trials.

The flow cytometry in oncology and immunology market size is expected to see rapid growth in the next few years. It will grow to $3.07 billion in 2028 at a compound annual growth rate (CAGR) of 10.0%. The anticipated growth in the forecast period can be ascribed to the integration with genomics and proteomics, the increasing adoption of single-cell analysis, the broadening applications in infectious diseases, the rise in cancer incidence, and the emergence of point-of-care flow cytometry. Notable trends expected in the forecast period include immunophenotyping for immunotherapy, the miniaturization of flow cytometry systems, multiparametric analysis, a shift towards spectral flow cytometry, and collaborative research initiatives.

The anticipated rise in cancer prevalence is poised to drive the growth of flow cytometry in the oncology and immunology market. Cancer, a group of disorders characterized by uncontrolled cell growth, is a significant area of focus for flow cytometry in studying cancer and immune cells. For example, Macmillan Cancer Support reported in October 2022 that approximately 3 million people had cancer in 2020, and projections estimate an increase to 3.5 million by 2025, 4 million by 2030, and 5.3 million by 2040. Hence, the increasing prevalence of cancer is a key factor propelling the growth of flow cytometry in the oncology and immunology markets.

The growing prevalence of HIV/AIDS is expected to contribute to the expansion of the flow cytometry market in oncology and immunology. HIV, a virus affecting the immune system, poses a global health challenge. Flow cytometry plays a crucial role in HIV/AIDS research and clinical applications by analyzing cells, especially immune cells, based on their physical and chemical properties. As of July 2023, the World Health Organization reported that approximately 39.0 million individuals were living with HIV in 2022, with an estimated range of 33.1 to 45.7 million. During the same period, around 630,000 people died due to HIV-related causes, with a confidence interval of 480,000 to 880,000. Moreover, approximately 1.3 million people contracted HIV in 2022, with a range of 1.0 to 1.7 million. Thus, the rising prevalence of HIV/AIDS is a significant driver for the growth of flow cytometry in the oncology and immunology market.

Technological advancements stand out as a prominent trend gaining traction in the flow cytometry market for oncology and immunology. Major players in this market are actively embracing innovative technologies to solidify their market positions. For example, in September 2022, Becton Dickinson and Company, a US-based medical technology provider, introduced the BD Research Cloud tailored for flow cytometry applications in oncology and immunology. This cloud-based software simplifies the flow cytometry process for researchers in fields such as immunology, virology, infectious disease, and oncology surveillance. Leveraging technologies such as BD Horizon RealYellow and RealBlue Reagents, along with the BD FACSDiscover S8 Cell Sorter featuring BD CellView Image Technology, BD aims to enhance flow cytometry capabilities, enabling researchers to optimize and advance their studies. BD Research Cloud, built on an industry-standard cloud infrastructure, is designed to complement BD equipment and reagents.

Companies in the flow cytometry market for oncology and immunology are also concentrating on innovative solutions such as automated sample preparation systems. An automated sample preparation system streamlines and automates various steps involved in preparing samples for analysis. For instance, in March 2022, Beckman Coulter Life Sciences, a US-based life science company, unveiled 'CellMek SPS,' a fully automated sample preparation system designed for clinical flow cytometry. This system offers on-demand processing for diverse sample types, enabling laboratories to expand their capabilities. CellMek SPS, building on a robust history of lab automation, integrates features that enhance efficiency by automating outdated manual preparation methods. This innovative system ensures a seamless workflow, delivering a continuous output of samples ready for analysis with complete traceability.

In July 2021, DiaSorin S.p.A., an Italy-based biotechnology company, completed the acquisition of Luminex Corporation for $1.8 billion. This strategic move by DiaSorin S.p.A. aims to strengthen its existing portfolio in the life science sector, fostering access to academic and scientific research, expanding collaboration with biopharma businesses, and enhancing overall market presence. Luminex Corporation, a US-based biotechnology company, specializes in providing flow cytometry solutions for oncology and immunology.

Major companies operating in the flow cytometry in oncology and immunology market report are Thermo Fisher Scientific Inc., Danaher Corporation, Merck KGaA, Becton Dickinson and Company, Laboratory Corporation of America Holdings, Agilent Technologies Inc., Sartorius AG, Beckman Coulter Inc., Bio-Rad Laboratories Inc., Sysmex Partec GmbH, OPKO Health Inc., Miltenyi Biotec, NeoGenomics Laboratories Inc., Luminex Corporation, Q2 Solutions LLC, Enzi Biochem Inc., DiaSorin S.p.A,BioLegend Inc., Cytek Biosciences Inc., Cell Signaling Technology Inc., Standard BioTools Inc., Sony Biotechnology Inc., NanoCellect Biomedical Inc., Nexcelom Bioscience LLC, CytoReason.

North America was the largest region in the flow cytometry in oncology and immunology market in 2023. The regions covered in the flow cytometry in oncology and immunology market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa

The countries covered in the flow cytometry in oncology and immunology market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Italy, Spain, Canada.

The flow cytometry in oncology and immunology market includes revenues earned by entities by providing services such as cell-based assay services, drug development services, and minimal residual disease (MRD) monitoring. The market value includes the value of related goods sold by the service provider or included within the service offering. The flow cytometry in oncology and immunology market also consists of sales of products flow cytometers, fluorescence-activated cell sorters (FACS), monoclonal antibodies, and fluorochromes. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Flow Cytometry In Oncology And Immunology Global Market Report 2024 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on flow cytometry in oncology and immunology market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 50+ geographies.
  • Understand how the market has been affected by the coronavirus and how it is responding as the impact of the virus abates.
  • Assess the Russia - Ukraine war's impact on agriculture, energy and mineral commodity supply and its direct and indirect impact on the market.
  • Measure the impact of high global inflation on market growth.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 3-5 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for flow cytometry in oncology and immunology ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The flow cytometry in oncology and immunology market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The impact of sanctions, supply chain disruptions, and altered demand for goods and services due to the Russian Ukraine war, impacting various macro-economic factors and parameters in the Eastern European region and its subsequent effect on global markets.

The impact of higher inflation in many countries and the resulting spike in interest rates.

The continued but declining impact of covid 19 on supply chains and consumption patterns.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

Markets Covered:

  • 1) By Type: Immunology; Oncology
  • 2) By Technology: Cell-Based Flow Cytometry; Bead-Based Flow Cytometry
  • 3) By Application: Translational Research; Clinical Research
  • 4) By End User: Hospitals; Diagnostic Laboratories; Reference Laboratories; Pharmaceutical And Biotechnology Companies; Academic Research Institutes; Contract Research Organizations; Other End Users
  • Companies Mentioned: Thermo Fisher Scientific Inc.; Danaher Corporation; Merck KGaA; Becton Dickinson and Company; Laboratory Corporation of America Holdings
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Flow Cytometry In Oncology And Immunology Market Characteristics

3. Flow Cytometry In Oncology And Immunology Market Trends And Strategies

4. Flow Cytometry In Oncology And Immunology Market - Macro Economic Scenario

  • 4.1. Impact Of High Inflation On The Market
  • 4.2. Ukraine-Russia War Impact On The Market
  • 4.3. COVID-19 Impact On The Market

5. Global Flow Cytometry In Oncology And Immunology Market Size and Growth

  • 5.1. Global Flow Cytometry In Oncology And Immunology Market Drivers and Restraints
    • 5.1.1. Drivers Of The Market
    • 5.1.2. Restraints Of The Market
  • 5.2. Global Flow Cytometry In Oncology And Immunology Historic Market Size and Growth, 2018 - 2023, Value ($ Billion)
  • 5.3. Global Flow Cytometry In Oncology And Immunology Forecast Market Size and Growth, 2023 - 2028, 2033F, Value ($ Billion)

6. Flow Cytometry In Oncology And Immunology Market Segmentation

  • 6.1. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Immunology
  • Oncology
  • 6.2. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Technology, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Cell-Based Flow Cytometry
  • Bead-Based Flow Cytometry
  • 6.3. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Translational Research
  • Clinical Research
  • 6.4. Global Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • Hospitals
  • Diagnostic Laboratories
  • Reference Laboratories
  • Pharmaceutical And Biotechnology Companies
  • Academic Research Institutes
  • Contract Research Organizations
  • Other End Users

7. Flow Cytometry In Oncology And Immunology Market Regional And Country Analysis

  • 7.1. Global Flow Cytometry In Oncology And Immunology Market, Split By Region, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 7.2. Global Flow Cytometry In Oncology And Immunology Market, Split By Country, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

8. Asia-Pacific Flow Cytometry In Oncology And Immunology Market

  • 8.1. Asia-Pacific Flow Cytometry In Oncology And Immunology Market Overview
  • Region Information, Impact Of COVID-19, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.3. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 8.4. Asia-Pacific Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

9. China Flow Cytometry In Oncology And Immunology Market

  • 9.1. China Flow Cytometry In Oncology And Immunology Market Overview
  • 9.2. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.3. China Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion
  • 9.4. China Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F,$ Billion

10. India Flow Cytometry In Oncology And Immunology Market

  • 10.1. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.2. India Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 10.3. India Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

11. Japan Flow Cytometry In Oncology And Immunology Market

  • 11.1. Japan Flow Cytometry In Oncology And Immunology Market Overview
  • 11.2. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.3. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 11.4. Japan Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

12. Australia Flow Cytometry In Oncology And Immunology Market

  • 12.1. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.2. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 12.3. Australia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

13. Indonesia Flow Cytometry In Oncology And Immunology Market

  • 13.1. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.2. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 13.3. Indonesia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

14. South Korea Flow Cytometry In Oncology And Immunology Market

  • 14.1. South Korea Flow Cytometry In Oncology And Immunology Market Overview
  • 14.2. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.3. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 14.4. South Korea Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

15. Western Europe Flow Cytometry In Oncology And Immunology Market

  • 15.1. Western Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 15.2. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.3. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 15.4. Western Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

16. UK Flow Cytometry In Oncology And Immunology Market

  • 16.1. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.2. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 16.3. UK Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

17. Germany Flow Cytometry In Oncology And Immunology Market

  • 17.1. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.2. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 17.3. Germany Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

18. France Flow Cytometry In Oncology And Immunology Market

  • 18.1. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.2. France Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 18.3. France Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

19. Italy Flow Cytometry In Oncology And Immunology Market

  • 19.1. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.2. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 19.3. Italy Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

20. Spain Flow Cytometry In Oncology And Immunology Market

  • 20.1. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.2. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 20.3. Spain Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

21. Eastern Europe Flow Cytometry In Oncology And Immunology Market

  • 21.1. Eastern Europe Flow Cytometry In Oncology And Immunology Market Overview
  • 21.2. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.3. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 21.4. Eastern Europe Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

22. Russia Flow Cytometry In Oncology And Immunology Market

  • 22.1. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.2. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 22.3. Russia Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

23. North America Flow Cytometry In Oncology And Immunology Market

  • 23.1. North America Flow Cytometry In Oncology And Immunology Market Overview
  • 23.2. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.3. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 23.4. North America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

24. USA Flow Cytometry In Oncology And Immunology Market

  • 24.1. USA Flow Cytometry In Oncology And Immunology Market Overview
  • 24.2. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.3. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 24.4. USA Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

25. Canada Flow Cytometry In Oncology And Immunology Market

  • 25.1. Canada Flow Cytometry In Oncology And Immunology Market Overview
  • 25.2. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.3. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 25.4. Canada Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

26. South America Flow Cytometry In Oncology And Immunology Market

  • 26.1. South America Flow Cytometry In Oncology And Immunology Market Overview
  • 26.2. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.3. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 26.4. South America Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

27. Brazil Flow Cytometry In Oncology And Immunology Market

  • 27.1. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.2. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 27.3. Brazil Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

28. Middle East Flow Cytometry In Oncology And Immunology Market

  • 28.1. Middle East Flow Cytometry In Oncology And Immunology Market Overview
  • 28.2. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.3. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 28.4. Middle East Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

29. Africa Flow Cytometry In Oncology And Immunology Market

  • 29.1. Africa Flow Cytometry In Oncology And Immunology Market Overview
  • 29.2. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Type, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.3. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By Application, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion
  • 29.4. Africa Flow Cytometry In Oncology And Immunology Market, Segmentation By End User, Historic and Forecast, 2018-2023, 2023-2028F, 2033F, $ Billion

30. Flow Cytometry In Oncology And Immunology Market Competitive Landscape And Company Profiles

  • 30.1. Flow Cytometry In Oncology And Immunology Market Competitive Landscape
  • 30.2. Flow Cytometry In Oncology And Immunology Market Company Profiles
    • 30.2.1. Thermo Fisher Scientific Inc.
      • 30.2.1.1. Overview
      • 30.2.1.2. Products and Services
      • 30.2.1.3. Strategy
      • 30.2.1.4. Financial Performance
    • 30.2.2. Danaher Corporation
      • 30.2.2.1. Overview
      • 30.2.2.2. Products and Services
      • 30.2.2.3. Strategy
      • 30.2.2.4. Financial Performance
    • 30.2.3. Merck KGaA
      • 30.2.3.1. Overview
      • 30.2.3.2. Products and Services
      • 30.2.3.3. Strategy
      • 30.2.3.4. Financial Performance
    • 30.2.4. Becton Dickinson and Company
      • 30.2.4.1. Overview
      • 30.2.4.2. Products and Services
      • 30.2.4.3. Strategy
      • 30.2.4.4. Financial Performance
    • 30.2.5. Laboratory Corporation of America Holdings
      • 30.2.5.1. Overview
      • 30.2.5.2. Products and Services
      • 30.2.5.3. Strategy
      • 30.2.5.4. Financial Performance

31. Flow Cytometry In Oncology And Immunology Market Other Major And Innovative Companies

  • 31.1. Agilent Technologies Inc.
  • 31.2. Sartorius AG
  • 31.3. Beckman Coulter Inc.
  • 31.4. Bio-Rad Laboratories Inc.
  • 31.5. Sysmex Partec GmbH
  • 31.6. OPKO Health Inc.
  • 31.7. Miltenyi Biotec
  • 31.8. NeoGenomics Laboratories Inc.
  • 31.9. Luminex Corporation
  • 31.10. Q2 Solutions LLC
  • 31.11. Enzi Biochem Inc.
  • 31.12. DiaSorin S.p.A
  • 31.13. BioLegend Inc.
  • 31.14. Cytek Biosciences Inc.
  • 31.15. Cell Signaling Technology Inc.

32. Global Flow Cytometry In Oncology And Immunology Market Competitive Benchmarking

33. Global Flow Cytometry In Oncology And Immunology Market Competitive Dashboard

34. Key Mergers And Acquisitions In The Flow Cytometry In Oncology And Immunology Market

35. Flow Cytometry In Oncology And Immunology Market Future Outlook and Potential Analysis

  • 35.1 Flow Cytometry In Oncology And Immunology Market In 2028 - Countries Offering Most New Opportunities
  • 35.2 Flow Cytometry In Oncology And Immunology Market In 2028 - Segments Offering Most New Opportunities
  • 35.3 Flow Cytometry In Oncology And Immunology Market In 2028 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer